Zuclopenthixol is an antipsychotic used for schizophrenia and other psychoses. In the UK, there are two injectable forms of zuclopenthixol: zuclopenthixol acetate : a short acting treatment used for acute episodes zuclopenthixol decanoate : a long acting treatment used for maintenance This week we launched a new measure to support a new type of alert […]
OpenPrescribing.net measure of seven day prescriptions for long-term conditions as a surrogate measure for Medicine Compliance Aids (MCAs). We measure seven day prescriptions for a basket of medicines; atorvastatin, simvastatin, levothyroxine, amlodipine and ramipril, commonly prescribed once daily for long term conditions.
At the DataLab we regularly collaborate on projects, both small and large, with users who get in touch. For development of this measure we would like to thank the NHS England Sustainable Unit and Centre for Sustainable Healthcare for their input on our work to support the NHS Long Term Plan. Another one of our […]
This is a brief blog about something small and trivial, but also big and important. Recently on the staircase my friend Carl Heneghan came out with a good line about “Patient and Public Involvement”, or “PPI” as it is known in the trade. “People talk about PPI,” he said: “but we need PPPI… patients, the […]
We’ve taken a quick look at the data to see why, despite the number of price concession lines have increased to 91 in November, the estimated total excess cost has reduced. (Reminder – we’ve used September prescribing data to estimate the effects, as that’s the latest data available). The full table is below, but here […]